Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AstraZeneca PLC | 501,893 | net | 04 Mar 2026 | tx 31+691,571−189,678 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 Mar 2026 | GRANT_AWARD | AstraZeneca PLC | 42,393 | 152.42 GBP | |
| 04 Mar 2026 | PURCHASE | AstraZeneca PLC | 4,863 | 0.00 GBP | |
| 04 Mar 2026 | PURCHASE | AstraZeneca PLC | 42,393 | 152.42 GBP | |
| 12 Nov 2025 | SALE | AstraZeneca PLC | 15,000 | 88.63 USD | |
| 12 Nov 2025 | SALE | AstraZeneca PLC | 15,000 | 88.63 USD | |
| 14 Aug 2025 | SALE | AstraZeneca PLC | 9,563 | 115.12 GBP | |
| 14 Aug 2025 | SALE | AstraZeneca PLC | 9,563 | 115.12 GBP | |
| 05 Mar 2025 | OTHER | AstraZeneca PLC | 28 | 0.00 GBP | |
| 04 Mar 2025 | GRANT_AWARD | AstraZeneca PLC | 2,021 | 0.00 GBP | |
| 04 Mar 2025 | GRANT_AWARD | AstraZeneca PLC | 51,737 | 119.63 GBP | |
| 17 Feb 2023 | OTHER | AstraZeneca PLC | 200 | 0.00 USD | |
| 10 Jun 2025 | OTHER | AstraZeneca PLC | 200 | 0.00 USD | |
| 04 Mar 2025 | PURCHASE | AstraZeneca PLC | 51,737 | 119.63 GBP | |
| 04 Mar 2024 | GRANT_AWARD | AstraZeneca PLC | 59,125 | 100.81 GBP | |
| 04 Mar 2024 | PURCHASE | AstraZeneca PLC | 59,125 | 100.81 GBP | first after silence |
| 05 May 2023 | SALE | AstraZeneca PLC | 19,470 | 74.81 USD | |
| 05 May 2023 | SALE | AstraZeneca PLC | 19,470 | 74.81 USD | |
| 04 Mar 2023 | GRANT_AWARD | AstraZeneca PLC | 45,449 | 108.21 GBP | |
| 04 Mar 2023 | PURCHASE | AstraZeneca PLC | 45,449 | 108.21 GBP | |
| 09 Feb 2023 | GRANT_AWARD | AstraZeneca PLC | 7,514 | 0.00 GBP | |
| 09 Feb 2023 | GRANT_AWARD | AstraZeneca PLC | 29,362 | 0.00 USD | |
| 22 Nov 2022 | SALE | AstraZeneca PLC | 32,711 | 65.58 USD | |
| 22 Nov 2022 | SALE | AstraZeneca PLC | 32,711 | 65.58 USD | |
| 29 Jul 2022 | GRANT_AWARD | AstraZeneca PLC | 67,523 | 0.00 USD | |
| 19 May 2022 | SALE | AstraZeneca PLC | 18,095 | 64.56 USD |
1 purchase reported after at least 12 months of silence — most recent on 04 Mar 2024.